Robin Harper Cowie - 10 Feb 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Signature
/s/ Robin Harper Cowie
Issuer symbol
BDSX
Transactions as of
10 Feb 2025
Net transactions value
-$22,794
Form type
4
Filing time
12 Feb 2025, 17:11:34 UTC
Previous filing
13 Nov 2024
Next filing
26 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +67,788 +33% 271,124 10 Feb 2025 Direct F1
transaction BDSX Common Stock Sale $22,794 -24,664 -9.1% $0.9242 246,460 11 Feb 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -3,157 -20% $0.000000 12,627 10 Feb 2025 Common Stock 3,157 Direct F1, F4
transaction BDSX Restricted Stock Units Options Exercise $0 -48,536 -33% $0.000000 97,070 10 Feb 2025 Common Stock 48,536 Direct F1, F5
transaction BDSX Restricted Stock Units Options Exercise $0 -16,095 -25% $0.000000 48,286 10 Feb 2025 Common Stock 16,095 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F3 The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.90 to $0.9536, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F5 These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F6 These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.